Back to Search
DANIEL WATTERSON, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1427326123Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
S018201(AZ)
Research & Publications (20)
Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation.
PMID 17521344·Epilepsia·2007
7-preclinical
Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression.
PMID 14501026·J Mol Neurosci·2003
7-preclinical
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.
PMID 19268602·Bioorg Med Chem·2009
7-preclinical
Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model.
PMID 19501063·Brain Res·2009
7-preclinical
[Penetrating peptide inhibitor of the myosin light chain kinase suppresses hyperpermeability of vascular endothelium].
PMID 19569527·Ross Fiziol Zh Im I M Sechenova·2009
7-preclinical
Structural insight into nucleotide recognition by human death-associated protein kinase.
PMID 19237746·Acta Crystallogr D Biol Crystallogr·2009
4-observational
Molecular properties and CYP2D6 substrates: central nervous system therapeutics case study and pattern analysis of a substrate database.
PMID 19661215·Drug Metab Dispos·2009
4-observational
Nest construction by a ground-nesting bird represents a potential trade-off between egg crypticity and thermoregulation.
PMID 19145449·Oecologia·2009
7-preclinical
The p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target.
PMID 19090985·BMC Neurosci·2008
6-review
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury.
PMID 18590543·J Neuroinflammation·2008
7-preclinical
Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.
PMID 18678415·J Neuroimmunol·2008
7-preclinical
A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns.
PMID 17577141·Shock·2007
7-preclinical
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
PMID 17784957·J Neuroinflammation·2007
4-observational
MLCK210 gene knockout or kinase inhibition preserves lung function following endotoxin-induced lung injury in mice.
PMID 17307813·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice.
PMID 17255312·Am J Pathol·2007
7-preclinical
Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
PMID 17920148·Neurosci Res·2007
7-preclinical
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.
PMID 17079143·Bioorg Med Chem Lett·2007
7-preclinical
De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders.
PMID 16842097·Curr Alzheimer Res·2006
6-review
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leak.
PMID 16996151·Biochim Biophys Acta·2006
7-preclinical
Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis.
PMID 17087515·Biochemistry·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 VICKERS AVE BLDG 1055
JBPHH, HI 96853 - Phone
- (808) 656-6850
Quick Facts
- NPI
- 1427326123
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile